Cargando…

Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy

BACKGROUND: IgA nephropathy (IgAN) is a major cause of chronic kidney disease (CKD). Renal interstitial fibrosis is a hallmark of CKD progression. Non-invasive biomarkers are needed to dynamically evaluate renal fibrosis. Data independent acquisition (DIA)-based liquid chromatography-mass spectromet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Jie, Wang, Meiling, Zhao, Man, Ni, Wentao, Zhang, Man
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029243/ https://www.ncbi.nlm.nih.gov/pubmed/36941570 http://dx.doi.org/10.1186/s12882-023-03103-7

Ejemplares similares

Albumin-to-fibrinogen ratio is an independent predictor of corticosteroid response and prognosis in patients with IgA nephropathy
por: Zhang, Yu, et al.
Publicado: (2023)

Elevated serum fibrinogen level is an independent risk factor for IgA nephropathy
por: Zhang, Ji, et al.
Publicado: (2017)

Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy
por: Wu, Changwei, et al.
Publicado: (2018)

Noninvasive Urinary Monitoring of Progression in IgA Nephropathy
por: Yang, Joshua Y. C., et al.
Publicado: (2019)

Urinary peptidome analysis in CKD and IgA nephropathy
por: Li, Zewen, et al.
Publicado: (2023)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Circulating TNF Receptors 1 and 2 Are Associated with the Severity of Renal Interstitial Fibrosis in IgA Nephropathy
por: Sonoda, Yuji, et al.
Publicado: (2015)

p38 MAPK activity is associated with the histological degree of interstitial fibrosis in IgA nephropathy patients
por: Lee, Jeonghwan, et al.
Publicado: (2019)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

Serum Levels of Joining Chain-Containing IgA1 Are Not Elevated in Patients with IgA Nephropathy
por: Li, Guanhong, et al.
Publicado: (2019)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Urinary miRNA profile for the diagnosis of IgA nephropathy
por: Szeto, Cheuk-Chun, et al.
Publicado: (2019)

Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
por: Zan, Jincan, et al.
Publicado: (2022)

Role of abnormal glycosylated IgA1 and interstitial transformation of glomerular endothelial cells in the development and progression of IgA nephropathy
por: Jia, Wanyu, et al.
Publicado: (2023)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Expression of MicroRNAs in the Urinary Sediment of Patients with IgA Nephropathy
por: Wang, Gang, et al.
Publicado: (2010)

Significance of Urinary Full-Length Megalin in Patients with IgA Nephropathy
por: Seki, Takuto, et al.
Publicado: (2014)

Elevated Urinary IL-6 Predicts the Progression of IgA Nephropathy
por: Zhao, Wenjun, et al.
Publicado: (2022)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Serum homocysteine is associated with tubular interstitial lesions at the early stage of IgA nephropathy
por: Li, Zizhen, et al.
Publicado: (2022)

Noninvasive evaluation of IgA nephropathy fibrosis using Doppler ultrasound
por: Qin, Xiachuan, et al.
Publicado: (2022)

Glomerular deposition of fibrinogen predicts good prognosis of IgA nephropathy: a single-center cohort study
por: Yang, Wei-guang, et al.
Publicado: (2023)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Underlying IgM heavy chain amyloidosis in treatment-refractory IgA nephropathy: A case report
por: Wu, Hai-Ting, et al.
Publicado: (2019)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Helicobacter pylori infection is associated with elevated galactose-deficient IgA1 in IgA nephropathy
por: Liu, Xing-Zi, et al.
Publicado: (2020)

Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy
por: Seo, Mi Seon, et al.
Publicado: (2013)

Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy
por: Wang, Nannan, et al.
Publicado: (2015)

Urinary CXCL1: A Novel Predictor of IgA Nephropathy Progression
por: Zhao, Yanfeng, et al.
Publicado: (2015)

Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy
por: Duan, Zhi-Yu, et al.
Publicado: (2016)

IgA nephropathy is associated with elevated urinary mitochondrial DNA copy numbers
por: Yu, Byung Chul, et al.
Publicado: (2019)

Association between urinary VEGFA and renal pathology of IgA nephropathy patients
por: Feng, Shaozhen, et al.
Publicado: (2021)

Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy
por: Yoon, Soo-Young, et al.
Publicado: (2023)

Clinicopathologic Significance of Predominant Lambda Light Chain Deposition in IgA Nephropathy
por: Ravipati, Prasanth, et al.
Publicado: (2022)

IgA nephropathy associated with thalassemia: a case report
por: Ni, Jun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ebie4skjc3m9p267p2r10lvhjp